Peter Olinga (P Olinga)

Scopus Author ID Researcher ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Topics

Systematic Review

Induced Pluripotent Stem Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mei Li, Frederik T Larsen, Marius C van den Heuvel, Konstanze Gier, Alan R Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E De Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions. Nutrients 16 (5) (2024)
Mei Li, Frederik T Larsen, Marius C van den Heuvel, Konstanze Gier, Alan R Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E De Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions. Nutrients 16 (5) (2024)
Carin Biel, Anniek Kastermans, Janneke Heidema, Martin Pehrsson, Charlotte Henstra, Joachim Mortensen, Klaas Nico Faber, Peter Olinga
Fibrogenesis in Human Mucosa and Muscularis Precision-Cut Intestinal Slices. Cells 13 (13) (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung (2024)
Carin Biel, Anniek Kastermans, Janneke Heidema, Martin Pehrsson, Charlotte Henstra, Joachim Mortensen, Klaas Nico Faber, Peter Olinga
Fibrogenesis in Human Mucosa and Muscularis Precision-Cut Intestinal Slices. Cells 13 (13) (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung 202 (3) (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung 202 (3) (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung 202 (3) (2024)
Mei Li, Frederik T Larsen, Marius C van den Heuvel, Konstanze Gier, Alan R Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E De Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions. Nutrients 16 (5) (2024)
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, Peter Olinga, Warisara Parichatikanond
Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice. Biomedicines 11 (1) (2023)
Herman J Woerdenbag, Peter Olinga, Ellen A Kok, Donald A P Brugman, Ulrike F van Ark, Arwin S Ramcharan, Paul W Lebbink, Frederik J H Hoogwater, Daan G Knapen, Derk Jan A de Groot, Maarten W Nijkamp
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment. Cancers 15 (7) (2023)
Femke A Elzinga, Behrad Khalili, Daniel J Touw, Paola Mian PharmD, Peter Olinga, Henri G D Leuvenink, Harry Van Goor, Sanne J Gordijn, Anika Nagelkerke, Paola Mian
Placenta-on-a-Chip as an In Vitro Approach to Evaluate the Physiological and Structural Characteristics of the Human Placental Barrier upon Drug Exposure: A Systematic Review. Journal of clinical medicine 12 (13) (2023)
Carin Biel, Klaas Nico Faber, Ruud A Bank, Peter Olinga
Matrix metalloproteinases in intestinal fibrosis. Journal of Crohn's & colitis (2023)
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, Peter Olinga, Warisara Parichatikanond
Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice. Biomedicines 11 (1) (2023)
Su Suriguga, Mei Li, Theerut Luangmonkong, Miriam Boersema, Koert P de Jong, Dorenda Oosterhuis, A R Gorter, Leonie Beljaars, Peter Olinga
Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure. American journal of physiology. Gastrointestinal and liver physiology 323 (2) (2022)
C Biel, O Martinec, B Sibering, K van Summeren, A M A Wessels, D J Touw, K P de Jong, V E de Meijer, K N Faber, J P Ten Klooster, I A M de Graaf, Peter Olinga
Extending the viability of human precision-cut intestinal slice model for drug metabolism studies. Archives of toxicology 96 (6) (2022)
R E H Karsten, N J W Krijnen, W Maho, H Permentier, E Verpoorte, Peter Olinga
Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis. Archives of toxicology 96 (9) (2022)
Charlotte Henstra, Jasper van Praagh, Peter Olinga, Anika Nagelkerke
The gastrointestinal microbiota in colorectal cancer cell migration and invasion. Clinical & experimental metastasis 38 (6) (2021)
Parichita Chakraborty, Dorenda Oosterhuis, Riccardo Bonsignore, Angela Casini, Peter Olinga, Dirk-Jan Scheffers
An Organogold Compound as Potential Antimicrobial Agent against Drug-Resistant Bacteria: Initial Mechanistic Insights. ChemMedChem 16 (19) (2021)
Camilla Grønkjær Jensen, Michael Schou Jensen, Stine Julie Tingskov, Peter Olinga, Rikke Nørregaard, Henricus A M Mutsaers
Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis. Biomedicines 9 (8) (2021)
Gerian G H Prins, Melany Rios-Morales, Albert Gerding, Dirk-Jan Reijngoud, Peter Olinga, Barbara M Bakker
The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices. Nutrients 13 (12) (2021)
Jasper van Praagh, J G de Wit, Peter Olinga, J J de Haan, W B Nagengast, R S N Fehrmann, K Havenga
Colorectal anastomotic leak: transcriptomic profile analysis. The British journal of surgery 108 (3) (2021)
Emilia Bigaeva, Nataly Puerta-Cavanzo, Elisabeth G D Stribos, Amos J de Jong, Carin Biel, Henricus A M Mutsaers, Michael Schou Jensen, Rikke Nørregaard, Anna M Leliveld, Igle J de Jong, Jan-Luuk Hillebrands, Harry Van Goor, Miriam Boersema, Ruud A Bank, Peter Olinga
Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis. Pharmaceutics 12 (5) (2020)
Adhyatmika Adhyatmika, Leonie Beljaars, Kurnia S S Putri, Habibie Habibie, Carian E Boorsma, Catharina Reker-Smit, Theerut Luangmonkong, Burak Guney, Axel Haak, Keri A Mangnus, Eduard Post, Klaas Poelstra, Kim Ravnskjaer, Peter Olinga, Barbro N Melgert
Osteoprotegerin is More than a Possible Serum Marker in Liver Fibrosis: A Study into its Function in Human and Murine Liver. Pharmaceutics 12 (5) (2020)
Fransien van Dijk, Christa M Hazelhoff, Eduard Post, Gerian G H Prins, Krista Rombouts, Klaas Poelstra, Peter Olinga, Leonie Beljaars
Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis. Pharmaceutics 12 (3) (2020)
Wouter Tobias van Haaften, Tjasso Blokzijl, Hendrik Sijbrand Hofker, Peter Olinga, Gerard Dijkstra, Ruud A Bank, Miriam Boersema
Intestinal stenosis in Crohn's disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets. Therapeutic advances in gastroenterology 13 (2020)
Gerian G H Prins, Peter Olinga
Potential implications of COVID-19 in non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Roberta Bartucci, Anna Salvati, Peter Olinga, Ykelien L Boersma
Vanin 1: Its Physiological Function and Role in Diseases. International journal of molecular sciences 20 (16) (2019)
Gerian G H Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus A M Mutsaers, Frank J Dekker, Peter Olinga
A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. Nutrients 11 (3) (2019)
Emilia Bigaeva, Emilia Gore, Eric Simon, Matthias Zwick, Anouk Oldenburger, Koert P de Jong, Hendrik S Hofker, Marco Schlepütz, Paul Nicklin, Miriam Boersema, Jörg F Rippmann, Peter Olinga
Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices. Archives of toxicology 93 (12) (2019)
Theerut Luangmonkong, Su Suriguga, Emilia Bigaeva, Miriam Boersema, Dorenda Oosterhuis, Koert P de Jong, Detlef Schuppan, Henricus A M Mutsaers, Peter Olinga
Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. British journal of pharmacology 174 (18) (2017)
W T van Haaften, J H Mortensen, M A Karsdal, Anne Christine Bay-Jensen, G Dijkstra, Peter Olinga
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease. Alimentary pharmacology & therapeutics 46 (1) (2017)